Oncology is the branch of medicine that deals with the study, diagnosis, and treatment of cancer.
肿瘤学是医学的一个分支，专门研究、诊断和治疗癌症。
The oncologist recommended a combination of chemotherapy and radiation therapy for her advanced breast cancer.
肿瘤学家建议她采用化疗和放疗来治疗晚期乳腺癌。
He underwent surgery to remove a malignant tumor in his lung.
他接受了手术，切除了肺部的恶性肿瘤。
She's undergoing oncological rehabilitation to regain her strength after chemotherapy.
她正在进行肿瘤康复治疗，以恢复化疗后的体力。
Her oncological assessment included a biopsy and a series of imaging tests.
她的肿瘤评估包括活检和一系列影像学检查。
Palliative
oncology focuses on improving the quality of life for patients with terminal cancer.
临终关怀肿瘤学关注的是改善晚期癌症患者的生存质量。
The breakthrough in immunotherapy has revolutionized the field of
oncology.
免疫疗法的突破彻底改变了肿瘤学领域。
The patient's oncological response to the new drug was excellent.
患者对新药的肿瘤学反应非常好。
Cancer research is a major focus in contemporary
oncology.
当代肿瘤学的重要研究方向是癌症研究。
The oncologist discussed the potential side effects and long-term prognosis with the patient.
肿瘤学家与患者讨论了潜在的副作用以及长期预后。
Gilead said it wanted to fully demonstrate innovative products in virology, oncology and other disease areas, as well as the innovative technologies behind many of its star products.
吉利德表示，希望充分展示病毒学、肿瘤学和其他疾病领域的创新产品，以及其许多明星产品背后的创新技术。
Novartis has about 10 radioligand therapy-related products in development, covering a range of oncology diseases.
诺华公司有大约10种放射性配体治疗相关产品正在开发中，涵盖一系列肿瘤疾病。
In the realm of healthcare innovation, AbbVie showcased a versatile array of pioneering products across five key focuses of areas, including immunology, oncology, eye care, neuroscience, and aesthetics.
在医疗保健创新领域，AbbVie展示了涵盖免疫学、肿瘤学、眼部护理、神经科学和美学等五个关键领域的一系列创新产品。
GSK will showcase its key advances and innovative capabilities in research and development in core therapeutic areas: infectious diseases, immunology and respiratory diseases, oncology, and HIV.
葛兰素史克将展示其在核心治疗领域研发的关键进展和创新能力：传染病、免疫学和呼吸系统疾病、肿瘤学和艾滋病毒。
Those Gilead innovative medicines that are available in China across virology, oncology and fungal infections will also be presented at CIIE.
吉利德在中国提供的病毒学、肿瘤学和真菌感染方面的创新药物也将在CIIE上展出。
Upbeat about the Chinese market, Kyowa Kirin Group, the Japanese pharmaceutical company that develops innovative specialty drugs, plans to further increase its investments and introduce a broader range of medications targeting conditions related to hematology and oncology, nephrology and rare diseases in China, said a senior executive.
一位高管表示，开发创新特效药的日本制药公司Kyowa Kirin Group对中国市场感到兴奋，计划进一步增加投资，并在中国推出更广泛的药物，针对血液学和肿瘤学、肾脏学和罕见病等相关疾病。
The company to date has successfully launched over 10 innovative drugs in China, spanning areas such as hematology and oncology, nephrology and rare diseases.
迄今为止，该公司已在中国成功推出了10多种创新药物，涵盖血液学和肿瘤学、肾脏学和罕见病等领域。
There were 17 trials ongoing in China in therapeutic areas such as cardiovascular, oncology, diagnostic imaging and hematology, he added.
他补充道，中国正在心血管、肿瘤学、诊断成像和血液学等治疗领域进行17项试验。
"We expect to introduce more than 25 innovative products into China between 2020 and 2025, covering immunity and inflammation, rare diseases and rare blood diseases, oncology, vaccines, cardiovascular and diabetes," Shi added.
施补充道：“我们预计在2020年至2025年期间将向中国引进超过25种创新产品，涵盖免疫和炎症、罕见病和罕见血液病、肿瘤学、疫苗、心血管和糖尿病。”。
The company established a global clinical data operations center in Chengdu, Sichuan province as early as 2018, and in 2021, it opened the Sanofi Institute for Biomedical Research in Suzhou, Jiangsu province — its first global research institute in China that focuses on cutting-edge biological research in major disease areas such as immunization and inflammation, oncology, rare diseases or rare blood disorders, neurology and diabetes.
该公司早在2018年就在四川省成都市建立了全球临床数据运营中心，并于2021年在江苏省苏州市开设了赛诺菲生物医学研究所，这是其在中国的第一家全球研究机构，专注于免疫与炎症、肿瘤学、，罕见病或罕见血液疾病、神经病学和糖尿病。
The company has also established strategic partnerships with various China-based biotech and tech companies such as Innovent Biologic, Insilico Medicine, Adagene and Baidu, to accelerate its pace in fields including oncology, AI drug discovery and antibody development technology.
该公司还与Innovent Biologic、Insilico Medicine、Adagene和百度等多家中国生物技术公司建立了战略合作伙伴关系，以加快其在肿瘤学、人工智能药物发现和抗体开发技术等领域的步伐。
"Thanks to the healthcare policies in China, Gilead Sciences has been growing rapidly in the country with 11 drugs approved over the past few years, addressing unmet medical needs in virology, oncology and invasive fungal disease… China is one of Gilead's key strategic markets, and we have a long-term commitment to patients in China and strong confidence in our long-term development here," said Jin Fangqian, vice president of Gilead Sciences and general manager of its China arm.
他说：“得益于中国的医疗政策，吉利德科学公司在中国迅速发展，在过去几年里批准了11种药物，解决了病毒学、肿瘤学和侵袭性真菌疾病方面未满足的医疗需求……中国是吉利德的关键战略市场之一，我们对中国的患者有着长期的承诺，并对我们在中国的长期发展充满信心。”金方谦，吉利德科学公司副总裁兼中国分公司总经理。
The company will continue to increase its research and development capability and expand its collaboration with the ecosystem that is developing in China, said Susan Galbraith, executive vice-president and head of oncology R&D at AstraZeneca during her trip to China last week.
阿斯利康执行副总裁兼肿瘤研发主管Susan Galbraith上周访问中国时表示，该公司将继续提高研发能力，并扩大与中国正在发展的生态系统的合作。
As of the end of 2022, Bayer and these three academic partners have carried out more than 110 research collaboration projects, including discovery and structural analysis of novel targets, pathogenesis and drug mechanism of action research, drug screening, efficacy evaluation as well as exploration on new modalities, new synthetic methods and innovative formulations, covering multiple therapeutic areas, such as, oncology, cardiovascular diseases, hematology and women's health.
截至2022年底，拜耳与这三个学术合作伙伴已开展了110多个研究合作项目，包括新靶点的发现和结构分析、发病机制和药物作用机制研究、药物筛选、疗效评估以及新模式、新合成方法和创新制剂的探索，涵盖肿瘤学、心血管疾病、血液学和妇女健康等多个治疗领域。
Shan said: "At this year's CIIE, we set up an 800-square-meter booth to showcase eight of our first-in-class/best-in-class innovative products and breakthrough therapies in the fields of oncology, rare diseases, gastroenterology, and plasma-derived therapies.
单说：“在今年的CIIE上，我们设立了一个800平方米的展位，展示了我们在肿瘤学、罕见病、胃肠病和血浆衍生疗法领域的八种一流/最佳创新产品和突破性疗法。
US-based pharmaceutical company Bristol Myers Squibb has brought 12 innovations in the areas of oncology, hematology, and immunology to the ongoing 5th China international Import Expo and will continue to help patients with unmet needs in China by introducing up to 30 innovative medicines or indications by 2025, said its China president.
总部位于美国的百时美施贵宝制药公司中国总裁表示，该公司已将肿瘤学、血液学和免疫学领域的12项创新成果带到正在举行的第五届中国国际进口博览会上，并将在2025年前推出多达30种创新药物或适应症，继续帮助中国需求未得到满足的患者。
The fifth China International Import Expo, kicking off on Saturday, is offering great opportunities for internationally leading pharmaceutical company Gilead Sciences to showcase its new discoveries in virology, oncology and mycology sciences, the company said.
吉利德公司表示，将于周六开幕的第五届中国国际进口博览会为国际领先的制药公司吉利德科学公司展示其在病毒学、肿瘤学和真菌学科学领域的新发现提供了绝佳机会。
The company is tapping into the field of oncology and mycology in China.
该公司正在开拓中国肿瘤学和真菌学领域。
The company's products, such as whole-genome sequencers, are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
该公司的产品，如全基因组测序仪，用于生命科学、肿瘤学、生殖健康、农业和其他新兴领域的应用。
Wang Sizhen, CEO of Genetron Health, a precision oncology platform specializing in cancer molecular profiling, said the company chose Changping because of the support from both the governmental and the park level.
专门研究癌症分子图谱的精准肿瘤平台Genetron Health的首席执行官王思珍表示，该公司之所以选择昌平，是因为得到了政府和园区层面的支持。
"With our commitment to oncology, Lilly strives to bring high-quality and affordable innovative drugs to Chinese cancer patients through both independent R&D and local partnerships.
“凭借我们对肿瘤学的承诺，礼来致力于通过独立研发和本地合作伙伴关系，为中国癌症患者带来高质量和负担得起的创新药物。
Berry Oncology, a leading Chinese company in genetic testing and early screening of tumors, plans to launch an early cancer screening product within the year that is capable in detecting six prevalent tumor types in China at one time, according to a senior executive of the company on Wednesday.
贝瑞肿瘤是中国领先的基因检测和肿瘤早期筛查公司，该公司一位高管周三表示，该公司计划在年内推出一种癌症早期筛查产品，能够一次检测出中国六种流行的肿瘤类型。
Through improving screening performance and optimizing the so-called HIFI technology, its self-developed tumor testing technology, the company aims to detect more than 20 tumor types through one-time blood draw with the product in the future, Wu Jiayan, Head of Berry Oncology Institutes, told a media briefing.
Berry肿瘤研究所所长吴家燕在一次媒体吹风会上表示，通过提高筛查性能和优化所谓的HIFI技术，即其自主研发的肿瘤检测技术，该公司的目标是在未来通过该产品一次性抽血检测20多种肿瘤类型。
Starting from the first liver cancer early screening product launched in August 2020, Berry Oncology has built early cancer screening models from multi-omics and multi-dimensional data, which lead to the emergence of the HIFI system.
从2020年8月推出的首款癌症早期筛查产品开始，Berry Oncology从多组学和多维数据构建了癌症早期筛查模型，这导致了HIFI系统的出现。
Zhou Jun, CEO of the company, said Berry Oncology not only focuses on the development and transformation of cutting-edge technologies, but also seeks to develop solutions with optimal balance between product cost and performance.
该公司首席执行官周军表示，Berry Oncology不仅专注于尖端技术的开发和转化，还寻求开发在产品成本和性能之间实现最佳平衡的解决方案。
Based on its expertise and experience with preventing and treating conditions from chronic diseases to rare diseases, Sanofi further optimizes resources to sharpen its R&D focus to first-in-class or best-in-class programs in vaccines and specialty care areas like immunology and oncology, where recent breakthroughs open up a world of new therapeutic opportunities.
基于其在预防和治疗从慢性病到罕见病等疾病方面的专业知识和经验，赛诺菲进一步优化资源，将研发重点放在疫苗和免疫学和肿瘤学等专业护理领域的一流或最佳项目上，在这些领域，最近的突破开辟了一个新的治疗机会世界。
Lu Shun, one of the country's leading experts in lung cancer and director of the department of oncology at the Shanghai Chest Hospital Affiliated with Shanghai Jiao Tong University, said there have been therapies in this disease area but their control of metastasis in the brain is insufficient and there exists an unmet clinical need.
癌症专家、上海交通大学附属上海胸科医院肿瘤科主任陆顺说，在这一疾病领域已经有了治疗方法，但他们对脑转移的控制不足，临床需求尚未得到满足。
This includes three innovative oncology drugs that have been approved for the China market, senior executives of the enterprise said at a meeting while releasing its 2021 performance on Friday.
该企业高管在周五发布2021年业绩时的一次会议上表示，这包括三种已获准进入中国市场的创新肿瘤药物。
The company with an 800-member research and development force in new drug discovery, development and manufacture — including 130 in the United States and Europe — said it is making rapid progress toward introducing its oncology drugs in the global market.
该公司在新药发现、开发和制造方面拥有800名研发人员，其中包括美国和欧洲的130名研发人员。该公司表示，在将其肿瘤药物推向全球市场方面进展迅速。
In the China market, the company said, its oncology and immune revenue nearly quadrupled and reached $119.6 million last year.
该公司表示，在中国市场，其肿瘤和免疫收入几乎翻了两番，去年达到1.196亿美元。
"We look forward to working with Adagene to design antibodies that can help us bring transformative new medicines to people living with cancer," said Valeria Fantin, global head of oncology research at Sanofi.
赛诺菲肿瘤研究全球负责人Valeria Fantin表示：“我们期待着与Adagene合作，设计抗体，帮助我们为癌症患者带来变革性的新药。”。
"Adagene's antibody platform is expected to help us precisely target established, but poorly addressed oncology mechanisms with best-in-class medicines," she said.
她说：“Adagene的抗体平台有望帮助我们用一流的药物准确靶向已建立但解决不力的肿瘤机制。”。
The company sees huge demand in the fields of oncology and cardiovascular disease in the country.
该公司看到了该国肿瘤学和心血管疾病领域的巨大需求。
Genetron Holdings Ltd, a leading precision oncology platform in China also known as Genetron Health, announced on Tuesday that it had signed a collaboration agreement with AstraZeneca R&D China for the joint development in China of next-generation sequencing-based tumor-informed minimal residual disease (MRD) tests for various solid tumors.
周二，中国领先的精准肿瘤平台Genetron Holdings Ltd（也称为Genetron Health）宣布，该公司已与阿斯利康研发中国有限公司签署合作协议，在中国联合开发用于各种实体瘤的下一代基于测序的肿瘤知情最小残留病（MRD）检测。
"As a leader in oncology, we will join hands with ecosystem partners, explore innovative models, and build a closed loop for screening, diagnosis, and treatment, with the ultimate goal of supporting the Healthy China 2030," said Vivian Bian, CEO of Roche Pharmaceuticals China.
罗氏制药中国首席执行官Vivian Bian表示：“作为肿瘤学领域的领导者，我们将与生态系统合作伙伴携手，探索创新模式，构建筛查、诊断和治疗的闭环，最终目标是支持健康中国2030。”。
The company has been marketing products in many specialized treatment fields such as oncology, transplantation immunity, urinary health and infection.
该公司一直在肿瘤学、移植免疫、泌尿健康和感染等许多专业治疗领域销售产品。
Beijing Astellas Medical will be responsible for the sales and marketing of oncology and specialized treatment products in China, and Astellas Pharma will further focus on production and manufacturing.
北京Astellas Medical将负责肿瘤和专业治疗产品在中国的销售和营销，Astellas Pharma将进一步专注于生产和制造。
Genetron Holdings Limited, or Genetron Health, a Nasdaq-listed Chinese precision oncology platform company that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced on Monday its strategic partnership with NeoGenomics Inc, a US-based Nasdaq-listed company that specializes in cancer genetic testing and information services.
Genetron Holdings Limited，简称Genetron Health，是一家在纳斯达克上市的中国精准肿瘤平台公司，专门提供分子图谱检测、癌症早期筛查产品和配套诊断开发，美国纳斯达克上市公司，专门从事癌症基因检测和信息服务。
This will encompass developing and operating clinical trials for both oncology drugs and their corresponding companion diagnostics products.
这将包括肿瘤药物及其相应配套诊断产品的开发和运营临床试验。
It signed a strategic cooperation agreement with Biocity, an innovative drug company focusing on the treatment of oncology and immune diseases.
它与专注于肿瘤和免疫疾病治疗的创新制药公司Biocity签署了战略合作协议。
Among the exhibitors this year are Bristol Myers Squibb, which is showcasing more than 15 innovative medicines and products currently in the pipeline related to oncology, hematology and immunology.
百时美施贵宝（Bristol Myers Squibb）是今年的参展商之一，该公司展示了目前正在开发的15多种与肿瘤学、血液学和免疫学相关的创新药物和产品。
Jean-Christophe Pointeau, president of Pfizer Biopharmaceutical Group China, said that these new products will cover the fields of oncology, vaccines, anti-infectives, inflammation and immunology, and rare disease areas.
辉瑞生物制药集团中国区总裁Jean-Christophe Pointeau表示，这些新产品将覆盖肿瘤学、疫苗、抗感染、炎症和免疫学以及罕见病领域。
Titled "Inventing for Life, for a Healthier China", a suite of exhibits highlight MSD's four-pronged areas of focus in the country: oncology, vaccines, diabetes and anti-infectives, along with animal health products.
以“发明创造，为了生活，为了一个更健康的中国”为主题，一系列展览重点展示了MSD在中国关注的四大领域：肿瘤学、疫苗、糖尿病和抗感染药物，以及动物保健产品。
An expert in oncology, rare diseases, gastroenterology, neuroscience and plasma-derived therapies, Japan-based Takeda is placing high hopes on China, which is projected to be the company's second-largest market by fiscal year 2031, thanks to an estimated 20 percent annual growth over the next five years.
作为一家在肿瘤学、罕见病、消化内科、神经科学和血源疗法领域拥有专业知识的公司，日本的武田制药对中国寄予厚望。预计到2031财年，中国将成为该公司第二大市场，未来五年年均增长率估计将达到20%。
Sanofi is scheduled to introduce at least 25 new products into the China market by 2025, covering therapies in areas such as immunology, rare diseases, oncology, rare blood disorders, neurology, cardiovascular disease and diabetes, as well as vaccines.
Sanofi计划在2025年前向中国市场推出至少25种新产品，涵盖免疫学、罕见病、肿瘤学、罕见血液疾病、神经科学、心血管疾病和糖尿病等领域，以及疫苗。
The center will cover areas such as oncology, respiratory conditions, immunology, rare diseases as well as cardiovascular, renal and metabolic disorders.
该中心将涵盖如肿瘤学、呼吸系统疾病、免疫学、罕见病，以及心血管、肾脏和代谢疾病等领域。
Clover Biopharmaceuticals, a Chinese clinical-stage biopharma company developing vaccines and oncology drugs, announced on Wednesday that its protein-based COVID-19 vaccine candidate was found to be 67 percent effective against COVID-19 of any degree of severity and 79 percent against the highly infectious Delta variant in a large late-stage trial.
中国临床阶段生物制药公司——三叶草生物制药有限公司周三宣布，其基于蛋白质的新冠疫苗在一项大型后期试验中被发现对任何严重程度的新冠肺炎的有效率为67%，对高传染性的德尔塔变异毒株的有效率为79%。
I'm convinced that more will come," added Mei, who is also chairman and CEO of the company dedicated to therapeutics in hematology and oncology.
“我确信还会有更多的好消息传来，”美博士补充道。他同时也是这家专注于血液学和肿瘤学治疗的公司董事长兼首席执行官。
I'm convinced that more will come," said Mei, who is also chairman and CEO of the company dedicated to therapeutics in hematology and oncology.
“我坚信会有更多的成果出现，”梅说道，他同时还是这家专注于血液学和肿瘤学治疗药物公司的董事长兼首席执行官。
Berry Oncology, a Chinese startup focusing on genomic testing of cancers, has completed a series B1 round of financing of nearly 700 million yuan ($99 million) which brought up its total fundraising to date to about 2 billion yuan.
专注于肿瘤基因检测的中国初创公司 Berry Oncology 已完成近 7 亿元人民币（9900 万美元）的 B1 轮融资，使其迄今为止的总融资额达到约 20 亿元人民币。
"During the process of gene sequencing, we acquire great amounts of genomic information, which doesn't specifically target one certain drug and satisfy pharmaceutical companies' various needs, such as the expansion of oncology drug indications, and the applicability for patients," he said.
“在进行基因测序的过程中，我们获得了大量的基因组信息，这些信息并不特指某一种药物，而是能满足制药公司各种需求，比如扩大癌症药物的适应症，提高药物对患者的适用性。”他说。
Under the terms of the agreement, Biogen will have exclusive rights to orelabrutinib in the MS field worldwide and certain autoimmune diseases outside of China (including Hong Kong, Macao and Taiwan), while InnoCare will retain exclusive worldwide rights to orelabrutinib in the field of oncology and certain autoimmune diseases in China, including Hong Kong, Macao and Taiwan.
根据协议条款，Biogen将在全球范围内获得orelabrutinib在多发性硬化症(MS)领域及中国(包括香港、澳门和台湾)以外的某些自身免疫疾病领域的独家权利；而InnoCare则将保留orelabrutinib在全球肿瘤学领域及在中国(包括香港、澳门和台湾)的某些自身免疫疾病领域的独家权利。
Biopharmaceutical research and development has been booming globally in recent years, and the number of clinical trials is increasing year by year, among which oncology clinical trials account for the largest proportion.
近年来，全球生物制药研究与开发蓬勃发展，临床试验数量逐年增加，其中肿瘤学临床试验占了最大比例。
"In terms of R&D in oncology, almost 80 percent of the early stage pipeline and two-thirds of the late-stage pipeline are controlled by emerging biopharmaceutical companies.
在肿瘤学研究与开发方面，近80%的早期阶段研发管线和三分之二的后期阶段研发管线由新兴生物制药公司控制。这句话的意思是，在癌症治疗领域的创新药物研发中，新兴的生物制药企业占据了主导地位，无论是处于研发初期的项目还是接近临床应用的项目，这些企业都拥有着大量的研发资源和项目。
In addition to producing oncology drugs, Janssens, who also is vice-chairman of the executive committee at the R&D-based Pharmaceutical Association in China, said Merck's cardiology, metabolism and endocrinology and fertility businesses also stay core to its overall healthcare business, given the plenty of unmet needs and untapped opportunities in China.
除了生产肿瘤药物外，作为中国研发型医药企业协会执行委员会副主席的杨森表示，默克的心血管、代谢和内分泌以及生殖健康业务也仍然是其整体医疗保健业务的核心，因为中国在这些领域存在大量未得到满足的需求和未开发的机会。
Genetron Holdings Ltd, a precision oncology platform company in China also known as Genetron Health, announced on Thursday a strategic partnership with JD Health, a subsidiary of Chinese e-commerce giant JD, to create innovative solutions for full-cycle cancer management.
中国精准肿瘤平台公司——基因泰克控股有限公司（Genetron Holdings Ltd，简称“基因泰克健康”）周四宣布与京东健康——中国电商巨头京东的子公司——建立战略合作关系，旨在为癌症管理全过程打造创新解决方案。
The partnership encompasses both online and offline components, and focuses on six key areas, which are consumer healthcare, digitization of liver disease management, government medical associations, sharing of customer screening resources, industry and user education, and consolidation of oncology doctors and experts on a single platform.
该合作包括线上和线下两个方面，主要集中在六个关键领域：消费者健康护理、肝病管理的数字化、政府医疗协会、共享客户筛查资源、行业和用户教育，以及在单一平台上整合肿瘤科医生和专家。
Wang Sizhen, co-founder and CEO of Genetron Health, said the partnership combines his company’s precision oncology capabilities with JD Health’s leading online healthcare platform in China, representing an innovative commercialization strategy for molecular diagnostics products in oncology.
歌纳生物科技的联合创始人兼首席执行官王思振表示，此次合作将公司的精准肿瘤学能力与京东健康在中国领先的在线医疗平台相结合，代表了分子诊断产品在肿瘤学领域的创新商业化策略。
Located in the Suzhou Industrial Park, the research institute, which is the fourth of its kind by the company after the three in France, Germany and the United States respectively, will focus on early-stage research in the areas of oncology, immunology and inflammation, the company said.
该公司表示，这家位于苏州工业园区的研究机构是继法国、德国和美国之后的第四家同类机构，将专注于肿瘤学、免疫学和炎症领域的早期研究。
Thanks to China's opening-up, Varian, which entered the Chinese market in 1983, has made several significant advances in radiation oncology.
得益于中国的开放政策，瓦里安于1983年进入中国市场，在放射肿瘤学领域取得了多项重大进展。
Berry Oncology, a subsidiary of China's leading gene sequencing company, announced Monday findings of a clinical research it initiated got published on Cell Research, marking a milestone in its development of a so-called HIFI tumor testing technology used in the research on early detection of liver cancer in cirrhotic patients.
中国领先的基因测序公司旗下子公司Berry Oncology周一宣布，其发起的一项临床研究发现已发表在《细胞研究》(Cell Research)杂志上，这标志着该公司开发的一种名为HIFI的肿瘤检测技术在肝硬化患者肝癌早期检测研究方面取得里程碑式进展。
Berry Oncology launched a national project called Precar in 2018, involving multiple centers as China's largest liver cancer screening project for early markers.
贝瑞奥科尼公司在2018年启动了一个名为"PreCar"的全国性项目，该项目涉及多个中心，成为中国最大的早期肝癌筛查项目，旨在寻找早期标志物。
Shanghai Yingli Pharmaceutical Co Ltd (Yingli Pharma), a small-molecule innovation drug research and development company, formed a new partnership with Jiangsu Hengrui Medicine Co Ltd (Hengrui Medicine) on Monday to accelerate the expansion of its oncology business in China, the second-largest pharmaceutical market in the world, the company said in a statement.
上海亿帆医药有限公司（亿帆医药），一家小分子创新药物研发公司，周一宣布与江苏恒瑞医药股份有限公司（恒瑞医药）建立新的合作伙伴关系，以加速其在中国——这个世界第二大药品市场的肿瘤业务扩张，该公司在一份声明中表示。
"Novartis Oncology and Novartis Pharmaceuticals expect to have seven new products approved in China in 2021.
诺华肿瘤学和诺华制药预计2021年将在中国市场获得七个新产品的批准。
The company also said a rolling submission of a new drug application of the oral capsule Surufatinib, an innovative oncology drug with independent research and development efforts, was initiated with the United States Food and Drug Administration in late December, and its marketing authorization application in Europe is being prepared.
该公司还表示，已于12月下旬开始向美国食品药品监督管理局提交口服胶囊Surufatinib的新药申请，并已启动滚动提交程序。Surufatinib是一种创新肿瘤药物，拥有独立的研发努力。同时，其在欧洲的上市许可申请也在准备之中。
Chen Kaixian, an academician with the Chinese Academy of Sciences, said the market launch of the medicine, the company's second oncology drug approved in China, provides a new solution to neuroendocrine tumor treatment.
中国科学院院士陈凯先表示，这款药物是该公司在中国获批的第二款抗癌药，它的上市为神经内分泌肿瘤治疗提供了新的解决方案。
The global Phase III clinical trial of fruquintinib, the company's first approved oncology drug in China, kicked off in September and is ongoing.
全球三期临床试验于九月启动，该公司在中国获批的第一个肿瘤药物弗喹替尼正在开展中。
The results of the interim analysis of the trial were presented at the 2020 American Society of Clinical Oncology Virtual Scientific Program.
该试验的中期分析结果在2020年美国临床肿瘤学会虚拟科学计划会议上公布。
The company said it will actively expand its business in oncology, providing therapeutic drugs and solutions to three million patients every day.
该公司表示，将积极扩展其在肿瘤学领域的业务，每天为300万患者提供治疗药物和解决方案。
The survey will base on a combination of offline questionnaires and a big data pool, which is expected to collect the information from 1,000 patients and their family members, 500 oncology doctors and 50 clinical pharmacists.
这项调查将基于离线问卷和大数据池的结合，目标是从1,000名患者及其家庭成员，500名肿瘤科医生和50名临床药剂师处收集信息。
About 40 percent of the company's annual R&D investment is in oncology, he said, adding Servier China is accelerating the introduction of its pancreatic cancer treatment liposome irinotecan injection.
他透露，公司每年约40%的研发投入用于肿瘤学领域，赛维利亚中国正在加快引进其胰腺癌治疗药物——紫杉醇脂质体注射液。
These newly unveiled offerings would center around key therapeutic areas such as immunity, oncology and ophthalmology, according to Tony Au, general manager of AbbVie China.
据艾伯维中国总经理Tony Au透露，这些新推出的产品将主要集中在免疫、肿瘤和眼科等关键治疗领域。
The plant currently produces medicines for oncology and gastroenterology－two of Takeda's four focused therapeutic areas, the company said.
Recent instances include Amgen signing a global collaboration for oncology drug development with BeiGene, and Lilly licensing a neutralizing antibody asset for COVID-19 from Junshi Biosciences.
Between January 2018 and September 2020, the company secured 25 medicine approvals in China in some disease areas with great patient need, including immunology, mental health, oncology, diabetes, infectious diseases, and rare diseases.
In China, Teva adopts a clear "3-3-3" strategy, meaning a focus on three therapeutically areas, namely central nervous system, respiratory conditions and oncology; three portfolio segments that range from innovative, complex generics and selective generics, as well as three big cities-Beijing, Shanghai and Guangzhou-for early-phase penetration in the country.
The drug is also the first self-developed cancer drug recommended by both the lymphoma treatment plan issued by the Chinese Society of Clinical Oncology and the United States National Comprehensive Cancer Network guidelines.
Wang Sizhen, co-founder and CEO of Genetron Holdings Ltd－a Beijing-based precision oncology company－said he is very impressed with the capability Chinese companies have demonstrated during the COVID-19 struggle.
Genetron Holdings Ltd, also known as Genetron Health, a Beijing-headquartered precision oncology company that aims to provide one-stop genomic profiling solutions for full-cycle cancer care, announced late Thursday it had donated a GENETRON S5 semiconductor high-throughput sequencer and supporting instruments to Wuhan Huoshenshan Hospital, which arrived at the hospital on Wednesday for immediate use.
The China market continued to show strong year-on-year revenue momentum of 40-percent growth for the first six months of Takeda's 2019 fiscal year, said Saroukos, making the country the fastest growing market for Takeda, whose key business areas touch upon oncology, gastroenterology, neuroscience and rare diseases, and the area of plasma-derived therapy.
The Beijing Xisike Clinical Oncology Research Foundation announced the launch of a new fund to promote the development of clinical and scientific research in China and support the cultivation of medical talent to ultimately benefit more Chinese cancer patients.
Li Jin, former chairman of the Chinese Society of Clinical Oncology, said that China has accelerated its pace of being integrated into the world’s new drug development in recent years, from which Chinese medical professionals’ experience in both clinical practice and clinical research has been enriched.
Yin Min, general manager of oncology at AstraZeneca China, said that the company is committed to exploring pathogenic mechanisms, treatment methods and innovative drugs to bring changes to the medical industry and help promote scientific progress in the oncology field.
Such strategic collaboration with local leading players is aimed to expand our oncology presence in China and to jointly advance Amgen's oncology pipeline in China and globally," Wan said.
"The disease is fatal in severe cases, and traditional medical solutions are mainly aimed to elevate platelet amounts to a safe level and reduce or avoid bleeding prove limited efficacy for some patients," said Chen Yu, executive director of the Hematological Department of the north campus of Ruijin Hospital Affiliated with the Shanghai Jiaotong University School of Medicine, during an event held by Novartis Oncology (China) at the ongoing China International Import Expo on Thursday.
Novartis Oncology showcased an innovative therapy in treating the disease.
Besides showcasing their most advanced innovative therapies - ranging from oncology and rare disease medication to personalized healthcare solutions - many enterprises are reaching new agreements with governments by bringing their latest therapies and technologies to meet patients' needs in the country, currently the world's second-largest pharmaceuticals market.
At CIIE 2019, AstraZeneca's cardiovascular and oncology departments also signed partnership agreements with enterprises from India and the United Kingdom, among the first batch of resident companies to develop comprehensive concrete collaborations regarding electrocardiogram diagnosis and ovarian cancer screening.
在2019年进博会期间，阿斯利康的心血管和肿瘤部门也与来自印度和英国的企业签署了合作协议，成为首批入驻并开展全面具体合作的企业之一，合作内容涉及心电图诊断和卵巢癌筛查。
Japanese biopharmaceutical company Takeda Pharmaceutical Co Ltd completed the purchase of Shire Plc in January, making rare diseases another key business area in addition to oncology, gastroenterology, and neuroscience among others in the company's global business blueprint.
The company focuses on discovering, licensing, developing and commercializing proprietary therapeutics for large unmet medical needs in China in areas such as oncology, autoimmune and infectious diseases.
The company also has in-house discovery capability focus for research and development of innovative drugs in oncology and autoimmune diseases.
In recent years, Fosun Pharma has expanded investment on innovation and oncology research, and worked on small molecular innovative drugs, biologics and cellular immunotherapy.
It owns a rich research pipeline, with more than 30 oncology projects at the clinical development stage.
The hospital will begin with various departments, including cardiology, obstetrics, oncology, orthopedics and pediatrics, with about 200 medical staff with half from abroad and half from the local community, he said.
We remain committed to our "patient-centric" philosophy, with a strong focus on multiple therapy areas where there is the most urgent demand from Chinese patients such as respiratory, cardiovascular, renal and digestive diseases, metabolic disorders and oncology.
"We focus on major diseases including cardiology, stroke, oncology and respiratory diseases to have developed integrated solutions including suites of systems, smart devices, software and services to meet the local customer needs.
The combined company will have nine products with more than $1 billion in annual sales, foreseeing significant potential for growth in oncology, immunology, and inflammation and cardiovascular disease.
Takeda, the biggest Asian pharmaceutical company, said it plans to list more than seven innovative drugs in China in the next five years, covering digestion, neuroscience and oncology.
"As the first immuno-oncology treatment product that will appear in the Chinese market, Opdivo is expected to become the new standard in the second-line treatment for NSCLC, according to Wu Yilong, chairman of Chinese Thoracic Oncology Group.
Merck Healthcare currently sells and manufactures 16 medicines in China covering seven major therapeutic areas, including oral anti-diabetes, oncology, cardiovascular disorders, infertility and thyroid diseases.
默克医疗目前在中国销售和制造的药品涵盖了七大主要治疗领域，包括口服抗糖尿病药物、肿瘤学药物、心血管疾病药物、不孕不育药物以及甲状腺疾病药物等共16种产品。
未经许可，严禁转发。QQ交流群：688169419